Parathyroid Imaging with SPECT-CT

  • Ken Herrmann
  • Ivan Santi
  • Andreas K. Buck
  • Ambros J. Beer


Hyperparathyroidism (HPT) is a common endocrine disorder affecting approximately 1 in 500 women and 1 in 2,000 men. The clinical or chemical diagnosis is commonly seen in the 5th through 7th decades of life [1]. Primary hyperparathyroidism (pHPT) is caused by a solitary parathyroid adenoma in approximately 85% of cases, whereas the remaining cases are often secondary HPT due to glandular hyperplasia, multiple adenomas and, very rarely, also parathyroid carcinomas [2].


Primary Hyperparathyroidism Parathyroid Adenoma Parathyroid Carcinoma Thyroid Lobe Radiotracer Uptake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR. 2007;188(6):1706–15.PubMedCrossRefGoogle Scholar
  2. 2.
    Ruda JM, Hollenbeak CS, Stack Jr BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132(3):359–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236(5):543–51.PubMedCrossRefGoogle Scholar
  4. 4.
    Lorenz K, Miccoli P, Monchik JM, Duren M, Dralle H. Minimally invasive video-assisted parathyroidectomy: multiinstitutional study. World J Surg. 2001;25(6):704–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99 m) technetium sestamibi scintigraphy. Clin Endocrinol (Oxf). 2002;57(2):241–9.CrossRefGoogle Scholar
  6. 6.
    Rickes S, Sitzy J, Neye H, Ocran KW, Wermke W. High-resolution ultrasound in combination with colour-Doppler sonography for preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism. Ultraschall Med. 2003;24(2):85–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Solorzano CC, Carneiro-Pla DM, Irvin 3rd GL. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg. 2006;202(1):18–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Stephen AE, Chen KT, Milas M, Siperstein AE. The coming of age of radiation-induced hyperparathyroidism: evolving patterns of thyroid and parathyroid disease after head and neck irradiation. Surgery. 2004;136(6):1143–53.PubMedCrossRefGoogle Scholar
  9. 9.
    Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med. 2003;44(6):904–8.PubMedGoogle Scholar
  10. 10.
    Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med. 2005;30(1):1–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Spanu A, Falchi A, Manca A, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med. 2004;45(1):40–8.PubMedGoogle Scholar
  12. 12.
    Blanco I, Carril JM, Banzo I, et al. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism. Clin Nucl Med. 1998;23(5):291–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med. 1997;38(6):834–9.PubMedGoogle Scholar
  14. 14.
    Pinero A, Rodriguez JM, Ortiz S, et al. Relation of biochemical, cytologic, and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2000;122(6):851–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Song AU, Phillips TE, Edmond CV, Moore DW, Clark SK. Success of preoperative imaging and unilateral neck exploration for primary hyperparathyroidism. Otolaryngol Head Neck Surg. 1999;121(4):393–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Gotthardt M, Lohmann B, Behr TM, et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg. 2004;28(1):100–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Buck AK, Nekolla S, Ziegler S, et al. Spect/Ct. J Nucl Med. 2008;49(8):1305–19.PubMedCrossRefGoogle Scholar
  18. 18.
    Lavely WC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48(7):1084–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Harris L, Yoo J, Driedger A, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck. 2008;30(4):509–17.PubMedCrossRefGoogle Scholar
  20. 20.
    Ruf J, Seehofer D, Denecke T, et al. Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin. 2007;46(1):15–21.PubMedGoogle Scholar
  21. 21.
    Gayed IW, Kim EE, Broussard WF, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46(2):248–52.PubMedGoogle Scholar
  22. 22.
    Krausz Y, Bettman L, Guralnik L, et al. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg. 2006;30(1):76–83.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Ken Herrmann
    • 1
  • Ivan Santi
    • 2
  • Andreas K. Buck
    • 1
  • Ambros J. Beer
    • 1
  1. 1.Department of Nuclear MedicineKlinikum rechts der Isar der Technischen Universität MünchenMunichGermany
  2. 2.U. O. Medicina NuclearePoliclinico S. Orsola-MalpighiBolognaItaly

Personalised recommendations